Advaita Bioinformatics Announces Marketing Partnership with LifeMap Sciences

Plymouth, MI – February 4, 2015 – Advaita Bioinformatics (Advaita) announced today that it has entered into a partnership with LifeMap Sciences, Inc. (LifeMap), a subsidiary of BioTime, Inc. (NYSE MKT:BTX), for the promotion and sale of Advaita’s flagship product, iPathwayGuide.  Under the agreement, iPathwayGuide will be featured across several of LifeMap’s products, including GeneCards® which is one of the most popular reference databases of human genes.

With the ever-increasing use of genetic sequencing, the volume of data available for analysis has grown exponentially.  Current methods for analyzing these data have been lagging.  Advaita’s iPathwayGuide has a unique approach that allows users to quickly identify the mechanisms that may be causing the condition being studied.  Advaita’s latest endeavors are targeted toward personalized medicine and leverage a cloud infrastructure to deliver results in minutes instead of weeks or months.

“We are very excited to work with LifeMap on this endeavor. Through our partnership, we will expose the usefulness and advance capabilities of iPathwayGuide to hundreds of thousands of LifeMaps’ users.” said Sorin Draghici, President and CEO, Advaita.  “We have already seen incredible interest for our software and this collaboration will continue to bring awareness of its advantages, as well as benefit the current LifeMap users.”

iPathwayGuide takes data from next-generation sequencing and other gene expression experiments and performs an Impact Analysis ™ to identify the gene signaling pathways that are impacted in the given condition.  “Through Impact Analysis™, iPathwayGuide considers the type, role, and position of each gene on the pathway, as well as all the gene-gene signals at the system level.  This virtually eliminates the false positives that are commonplace with other pathway analysis applications, as well as greatly enhances our ability to find the truly impacted pathways.” explained Advaita’s Vice President, Andrew Olson. iPathwayGuide also performs a number of other analyses including, differential expression, GO analysis, prediction of micro RNAs (miRNAs), diseases, meta-analysis and allows users to model drugs, miRNAs, and SNPs directly on pathways.

iPathwayGuide is a free-to-use web-based application.  Users can freely upload and analyze their data without charge.  The results of each analysis are available to the user for a period of time to asses their usefulness.  If deemed useful, users may purchase unlimited access to the analysis results.